Local Corticosteroid Injection Versus Open Surgical Release in De Quervain Tenosynovitis: A Prospective Non-Randomized Comparative Study
Journal of Rawalpindi Medical College · 2026
DOI: 10.37939/jrmc.3240 ↗Abstract
Objective: De Quervain tenosynovitis is a frequent cause of radial-sided wrist pain in clinical practice and is a stenosing tendinopathy involving the first dorsal extensor compartment of the wrist. Corticosteroid injection and surgical release are widely used for its treatment; however, there is a lack of comparative evidence on the effectiveness of these treatments in a real clinical setting. Methods: In this prospective, non-randomised, single-centre comparative study (ClinicalTrials.gov: NCT07683429), 100 patients with clinically diagnosed De Quervain tenosynovitis who failed to respond to initial conservative treatment were enrolled. Forty-nine patients were allocated to corticosteroid injection (CSI), and 51 to open surgical release (OSR) treatment, based on the investigators' clinical judgment and patient choice. The Visual Analogue Scale (VAS, 0-10) was used to measure pain severity at baseline, 1 month, and 6 months after the intervention. Independent samples t-tests were used to compare the differences between groups, and a linear mixed-effects model was used to model pain trajectories over time. The normality of continuous variables was checked before parametric analysis using the Shapiro-Wilk test. A trained assessor blinded to the treatment allocation performed the VAS assessments at follow-up. Results: Most of the cohort (72%) were women, and the mean age was 36.7 ± 8.0 years. There were no significant differences in age or sex between the two groups; however, the VAS scores were slightly higher in the surgical group (8.71 ± 1.06) than in the CSI group (8.27 ± 0.97; p = 0.033) at baseline. The surgical release group had significantly lower pain scores at 1 month (1.49 ± 0.78) than the CSI group (3.22 ± 1.07; p < 0.001). This difference persisted and widened at six months (surgical: 0.59 ± 0.57 versus CSI: 2.88 ± 1.18; p < 0.001). There was a significant group × time interaction (p < 0.001) for the linear mixed-effects modelling for pain scores over follow-up, indicating that the surgical release group had greater and more lasting reductions in pain. No significant complications were observed in either group. Conclusion: Corticosteroid injection and open surgical release are effective treatments for De Quervain tenosynovitis. Surgical release was more effective and long-lasting in relieving pain, particularly in cases of chronic or intractable pain. However, corticosteroid injection remains a minimally invasive first-line treatment. Treatment decisions should be based on the severity of symptoms, patient preference, and available resources. Keywords: De Quervain tenosynovitis; corticosteroid injection; surgical release; visual analog scale; prospective non-randomized comparative study.
EUVIMED